Metropolitan Life Insurance Company (MetLife)’s Medifast MED Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-601	Closed	-$23K	–	1258
2024 Q1	$23K	Hold	601	–	–	﹤0.01%	1787
2023 Q4	$40.4K	Hold	601	–	–	﹤0.01%	1560
2023 Q3	$45K	Hold	601	–	–	﹤0.01%	1461
2023 Q2	$55.4K	Buy	601 +41	+7%	+$3.65K	﹤0.01%	1363
2023 Q1	$58.1K	Sell	560 -134	-19%	-$14.8K	﹤0.01%	1309
2022 Q4	$80.1K	Hold	694	–	–	﹤0.01%	1187
2022 Q3	$75.2K	Hold	694	–	–	﹤0.01%	1187
2022 Q2	$125K	Hold	694	–	–	0.01%	931
2022 Q1	$119K	Sell	694 -2,220	-76%	-$419K	﹤0.01%	1091
2021 Q4	$610K	Sell	2,914 -205	-7%	-$42.4K	0.01%	1291
2021 Q3	$601K	Hold	3,119	–	–	0.01%	1328
2021 Q2	$883K	Buy	3,119 +161	+5%	+$43.6K	0.01%	1112
2021 Q1	$627K	Sell	2,958 -362	-11%	-$86.6K	0.01%	1278
2020 Q4	$652K	Hold	3,320	–	–	0.01%	1192
2020 Q3	$546K	Sell	3,320 -392	-11%	-$64.5K	0.01%	1156
2020 Q2	$515K	Sell	3,712 -96	-3%	-$8.81K	0.01%	1171
2020 Q1	$238K	Buy	3,808 +154	+4%	+$14K	﹤0.01%	1494
2019 Q4	$400K	Sell	3,654 -139	-4%	-$13.5K	0.01%	1464
2019 Q3	$393K	Hold	3,793	–	–	0.01%	1443
2019 Q2	$487K	Hold	3,793	–	–	0.01%	1322
2019 Q1	$484K	Hold	3,793	–	–	0.01%	1323
2018 Q4	$474K	Hold	3,793	–	–	0.01%	1219
2018 Q3	$840K	Hold	3,793	–	–	0.01%	1028
2018 Q2	$607K	Buy	3,793 +401	+12%	+$51.3K	0.01%	1185
2018 Q1	$317K	Hold	3,392	–	–	﹤0.01%	1576
2017 Q4	$237K	Sell	3,392 -4,330	-56%	-$287K	﹤0.01%	1804
2017 Q3	$458K	Hold	7,722	–	–	﹤0.01%	1745
2017 Q2	$320K	Hold	7,722	–	–	﹤0.01%	2017
2017 Q1	$343K	Hold	7,722	–	–	﹤0.01%	1917
2016 Q4	$321K	Hold	7,722	–	–	﹤0.01%	2045
2016 Q3	$292K	Hold	7,722	–	–	﹤0.01%	2086
2016 Q2	$257K	Sell	7,722 -888	-10%	-$28.7K	﹤0.01%	2148
2016 Q1	$260K	Hold	8,610	–	–	﹤0.01%	2012
2015 Q4	$262K	Buy	8,610 +1,525	+22%	+$45.4K	﹤0.01%	2052
2015 Q3	$190K	Sell	7,085 -3,611	-34%	-$105K	﹤0.01%	2316
2015 Q2	$346K	Buy	+10,696	New	+$339K	﹤0.01%	2018
2015 Q1	–	Sell	-11,310	Closed	-$379K	–	2347
2014 Q4	$379K	Hold	11,310	–	–	﹤0.01%	1957
2014 Q3	$371K	Hold	11,310	–	–	﹤0.01%	1921
2014 Q2	$344K	Hold	11,310	–	–	﹤0.01%	2097
2014 Q1	$329K	Hold	11,310	–	–	﹤0.01%	2088
2013 Q4	$296K	Hold	11,310	–	–	﹤0.01%	2194
2013 Q3	$304K	Hold	11,310	–	–	﹤0.01%	2094
2013 Q2	$291K	Buy	+11,310	New	+$297K	﹤0.01%	2066

Other funds holding MED

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MED Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Medifast (MED) in Q2 2024, closing a stake of 601 shares — an estimated $23K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MED in Q2 2013 and held it in 43 quarters. The position peaked at $883K in Q2 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 601 Medifast shares in Q2 2024, an estimated $23K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Medifast in Q2 2013 and held it in 43 quarters.
Metropolitan Life Insurance Company (MetLife)'s Medifast position peaked at $883K in Q2 2021.
158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.